2007 Press Releases
December 11th, 2007
ChemGenex Investigators Report Omacetaxine Effective in Killing CML Stem Cells in Animal Model Studies
December 10th, 2007
ChemGenex Investigators Report Activity of Omacetaxine in Imatinib-Resistant Chronic Myeloid Leukemia Patients with the T315I Mutation
December 6th, 2007
ChemGenex Appoints Donald Santel to Board of Directors
December 4th, 2007
ChemGenex Announces Poster Presentations at the 49th Annual Meeting of the American Society of Hematology
November 29th, 2007
ChemGenex Announces Shareholder Approval to Demerge Verva Pharmaceuticals
October 30th, 2007
ChemGenex Pharmaceuticals to Present at Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference
October 29th, 2007
ChemGenex Announces Strategic Restructuring of Company to Focus on Late-Stage Cancer Portfolio
October 1st, 2007
ChemGenex Announces Positive Preliminary Data from Phase 2/3 Clinical Trial of Ceflatonin® at International Conference
September 24th, 2007
ChemGenex Announces Second Publication Demonstrating Activity of Ceflatonin® in T315I-Positive Chronic Myeloid Leukemia
June 12th, 2007
ChemGenex Announces Publication Confirming Activity of Ceflatonin® in T315I-Positive CML
May 30th, 2007
ChemGenex Appoints Dr George Morstyn to Board of Directors
May 21st, 2007
Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML
April 17th, 2007
ChemGenex Reports Preclinical Data at American Association of Cancer Research (AACR) Annual Conference
April 4th, 2007
ChemGenex Announces Initiation of Second Phase 2/3 Clinical Trial for Ceflatonin® in CML
April 3rd, 2007
ChemGenex Announces the Completion of A$21 Million Financing
February 14th, 2007
Clinical Data Supporting Development of ChemGenex’s Ceflatonin® Published in Cancer
February 13th, 2007
ChemGenex Announces Appointment of Two Experienced Non-Executive Directors
February 8th, 2007
ChemGenex Announces New Significant Investors, Completes Capital Raising, Announces Rights Issue and Board Changes
February 1st, 2007